Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 14, 2014; 20(22): 7034-7039
Published online Jun 14, 2014. doi: 10.3748/wjg.v20.i22.7034
Published online Jun 14, 2014. doi: 10.3748/wjg.v20.i22.7034
Study | Group | Polyp detection rate | Adenoma detection rate | Polyps per patient (n) | Adenomas per patient (n) |
Byun et al[20] | Hyoscine butylbromide | 45.6% | 35.0% | NR | NR |
Placebo | 39.2% | 29.4% | |||
Lee et al[21] | Hyoscine butylbromide | 34.5% | NR | 0.9 ± 1.8 | NR |
Placebo | 25.9% | 0.6 ± 1.2 | |||
Corte et al[10] | Hyoscine butylbromide | 43.6% | 27.1% | 0.91 ± 0.084 | 0.55 ± 0.073 |
Placebo | 36.6% | 21.8% | 0.70 ± 0.075 | 0.42 ± 0.062 | |
de Brouwer et al[15] | Hyoscine butylbromide | 55.9% | 29.7% | 1.13 | NR |
Placebo | 60.2% | 31.4% | 1.21 | ||
Rondonotti et al[16] | Hyoscine butylbromide | 38.6% | 31.7% | NR | NR |
Placebo | 37.0% | 28% |
- Citation: Cui PJ, Yao J, Han HZ, Zhao YJ, Yang J. Does hyoscine butylbromide really improve polyp detection during colonoscopy? A meta-analysis of randomized controlled trials. World J Gastroenterol 2014; 20(22): 7034-7039
- URL: https://www.wjgnet.com/1007-9327/full/v20/i22/7034.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i22.7034